Axa SA (CS) Given a €28.80 Price Target by Jefferies Group LLC Analysts
Axa SA (EPA:CS) received a €28.80 ($33.88) price target from equities researchers at Jefferies Group LLC in a research report issued to clients and investors on Monday, July 10th. The brokerage presently has a “buy” rating on the stock.
Other research analysts have also recently issued research reports about the stock. Kepler Capital Markets set a €27.70 ($32.59) price target on shares of Axa SA and gave the stock a “buy” rating in a report on Thursday, May 11th. Baader Bank set a €26.50 ($31.18) price target on shares of Axa SA and gave the stock a “buy” rating in a report on Wednesday, March 29th. J P Morgan Chase & Co set a €27.80 ($32.71) price target on shares of Axa SA and gave the stock a “buy” rating in a report on Wednesday, April 19th. Finally, Royal Bank Of Canada set a €28.00 ($32.94) price target on shares of Axa SA and gave the stock a “buy” rating in a report on Friday, May 26th. One analyst has rated the stock with a sell rating, eight have issued a hold rating and ten have assigned a buy rating to the company. Axa SA has a consensus rating of “Hold” and a consensus target price of €26.56 ($31.24).
Shares of Axa SA (EPA CS) traded up 1.05% during midday trading on Monday, hitting €25.47. The company’s stock had a trading volume of 6,876,028 shares. The stock’s 50 day moving average is €24.60 and its 200-day moving average is €23.86. Axa SA has a 52-week low of €16.94 and a 52-week high of €25.80. The firm has a market cap of €61.62 billion and a P/E ratio of 11.08.
About Axa SA
AXA SA (AXA) is a France-based holding company engaged in the business of financial protection. The Company’s segments include Life & Savings, Property & Casualty, Asset Management , Banking and Holding companies. The Life & Savings segment’s products include a range of investment and savings products, as well as Protection and Health products.
Receive News & Stock Ratings for Axa SA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axa SA and related stocks with our FREE daily email newsletter.